J. Bitran

J. Vose, J. Winter, P. Hari, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sequential scintigraphic staging of small cell carcinoma

J. Bitran, C. Bekerman, S. Pinsky, 1981, Cancer.

The predictive value of serial bone scans in assessing response to chemotherapy in advanced breast cancer

J. Bitran, R. Desser, C. Bekerman, 1980, Cancer.

Current concepts in small cell carcinoma of the lung

K. Albain, H. Golomb, J. Bitran, 1984, CA: a cancer journal for clinicians.

Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 study.

R. Weichselbaum, E. Vokes, H. Golomb, 1989, Chest.

Protochemotherapy in non‐small cell lung carcinoma. An attempt to increase surgical resectability and survival. A preliminary report

A. Little, S. Purl, K. Albain, 1986, Cancer.

Gallium-67 scanning for carcinoma of the lung.

D. Skinner, N. Gross, T. Demeester, 1976, The Journal of thoracic and cardiovascular surgery.

Intracavitary bleomycin for the control of malignant effusions

J. Bitran, C. Brown, M. Kozloff, 1981, Journal of surgical oncology.

Camp chemotherapy for metastatic non‐oat cell bronchogenic carcinoma. A 7‐year experience (1975–1981) with 160 patients

T. Demeester, H. Golomb, S. Newman, 1985, Cancer.

Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.

L. Rubenstein, M. Griem, T. Demeester, 1976, Cancer treatment reports.

Splenic abscesses due to Mycobacterium tuberculosis in patients with AIDS.

J. Bitran, I. Levy, R. Northland, 1991, Reviews of infectious diseases.

Management of locally advanced and inflammatory carcinoma of the breast.

S. Ackland, J. Bitran, K. Dowlatshahi, 1985, Surgery, gynecology & obstetrics.

Gallium-67 citrate imaging studies of the lung.

P. Hoffer, J. Bitran, R. Gupta, 1980, Seminars in nuclear medicine.

In-Vitro Resistance to Zidovudine and Alpha-interferon in HIV-1 Isolates from Patients: Correlations with Treatment Duration and Response

R. Weinstein, B. Edlin, P. Pitha, 1992, Annals of Internal Medicine.

Doxorubicin cardiotoxicity and melphalan.

J. Bitran, 1981, Annals of internal medicine.

Idiopathic acquired refractory sideroblastic anemia: Banded chromosome analysis in six patients.

J. Rowley, H. Golomb, J. Bitran, 1977, Acta haematologica.

Efficacy and safety of clofarabine in relapsed and/or refractory non‐hodgkin lymphoma, including rituximab‐refractory patients

P. Venugopal, C. Nabhan, W. Fried, 2011, Cancer.

Chemotherapy of metastatic non-small cell bronchogenic carcinoma.

H. Golomb, J. Bitran, P. Hoffman, 1983, Seminars in oncology.

Chemotherapy for stage IV non-small cell lung cancer.

E. Vokes, J. Bitran, 1990, Hematology/oncology clinics of North America.

Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM).

J. Bitran, M. Kozloff, C. Shapiro, 1979, Cancer treatment reports.

A Review of the Abscopal Effect in the Era of Immunotherapy

J. Bitran, Edward Nabrinsky, J. Macklis, 2022, Cureus.

High‐dose, multiple‐alkylator chemotherapy with autologous bone marrow reinfusion in patients with advanced non‐small cell lung cancer

H. Golomb, J. Bitran, P. Hoffman, 1989, Cancer.

Remission of uterine leiomyosarcomas treated with vincristine, Adriamycin, and dimethyl-triazeno-imidazole carboximide.

F. Azizi, A. Herbst, J. Bitran, 1979, American journal of obstetrics and gynecology.

Cancer and Preganancy

J. Bitran, Stephanie F. Williams, S. Williams, 1985 .

Acute nephrotoxicity following cis‐dichlorodiammine‐platinum

J. Bitran, M. Kozloff, C. Shapiro, 1982, Cancer.

High-dose myeloablative therapy and autologous peripheral blood progenitor cell transplantation for elderly patients (greater than 65 years of age) with relapsed large cell lymphoma.

J. Bitran, J. Kosirog-Glowacki, D. Link, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The role of high-dose therapy and autologous bone marrow reinfusion in the treatment of Hodgkin's disease.

J. Bitran, S. Williams, 1989, Hematology/oncology clinics of North America.

Diffuse histiocytic lymphoma with sclerosis: A clinicopathologic entity frequently causing superior venacaval obstruction

J. Kinzie, J. Ultmann, H. Golomb, 1981, Cancer.

5‐Fluorouracil With Oral Leucovorin and Hydroxyurea and Concomitant Radiotherapy for Stage III Non‐Small Cell Lung Cancer

E. Vokes, Srinivasan Vijayakumar, S. Krishnasamy, 1990, Cancer.

Platinol (CDDP) and continuous intravenous infusion 5-fluorouracil in refractory stage IV breast cancer: a phase II study.

J. Bitran, M. Kozloff, R. Desser, 1990, Cancer investigation.

Small‐cell carcinoma of the lung: A five‐year experience with combined modality therapy

L. Gordon, M. Griem, T. Demeester, 1980, Cancer.

Lactic acidosis and diffuse histiocytic lymphoma (DHL)

J. Ultmann, J. Bitran, D. Sweet, 1978, American journal of hematology.

Immunologic Status of Patients in Remission from Hodgkin's Disease and Disseminated Malignancies

M. Telfer, J. Bitran, M. Kozloff, 1987 .

Zidovudine-Interferon-α Combination Therapy in Patients with Advanced Human Immunodeficiency Virus Type 1 Infection: Biphasic Response of p24 Antigen and Quantitative Polymerase Chain Reaction

R. Weinstein, P. Connolly, B. Edlin, 1992 .

Reducing Unwarranted Oncology Care Variation Across a Clinically Integrated Network: A Collaborative Physician Engagement Strategy.

J. Peabody, J. Bitran, David Paculdo, 2019, Journal of oncology practice.

Combined modality therapy for stage III non-small cell lung cancer : the University of Chicago experience

W. Gradishar, E. Vokes, H. Golomb, 1991 .

MAGNIFY: Phase IIIb Randomized Study of Lenalidomide Plus Rituximab (R2) Followed By Lenalidomide Vs. Rituximab Maintenance in Subjects with Relapsed/Refractory Follicular, Marginal Zone, or Mantle Cell Lymphoma

K. Foon, A. Yacoub, J. Bitran, 2016 .

Chemotherapy for non-small cell lung cancer. The continuing challenge.

E. Vokes, N. Vogelzang, J. Bitran, 1991, Chest.

A phase I-II study of bialkylator chemotherapy, high-dose thiotepa, and cyclophosphamide with autologous bone marrow reinfusion in patients with advanced cancer.

S. Purl, C. Westbrook, J. Bitran, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patients with Relapsed or Refractory- Hodgkin's Disease

R. Weichselbaum, J. Bitran, J. Moormeier, 1991 .

Sequential staging in bronchogenic carcinoma.

H. MacMahon, T. Demeester, K. Rezai, 1979, Chest.

Zidovudine-interferon-alpha combination therapy in patients with advanced human immunodeficiency virus type 1 infection: biphasic response of p24 antigen and quantitative polymerase chain reaction.

R. Weinstein, P. Connolly, B. Edlin, 1992, The Journal of infectious diseases.

Prognostic factors in patients with non‐small cell bronchogenic carcinoma and brain metastases

T. Demeester, H. Golomb, S. Newman, 1982, Cancer.

The management of cardiac tamponade in patients with breast cancer

J. Bitran, C. Brown, R. Evans, 1984, Journal of surgical oncology.

First, once a certain regimen becomes the standard of care, this implies that an alternative approach by definition is an inferior thera- peuticoption.Webelievethatthestandardofcareinthetreatmentof patientswithnewlydiagnosedMMistoattemptattainingaremission inpreparationforstemcelltransplant(SCT)prov

P. Richardson, C. Nabhan, J. Bitran, 2006 .

Secondary hyperparathyroidism in acute renal failure from rhabdomyolysis.

J. Bitran, 1976, Annals of internal medicine.

Multiple sebaceous gland tumors and internal carcinoma: Torre's syndrome

J. Bitran, E. Pellettiere, Edmund V. Pellettiere, 1974, Cancer.

Tamoxifen in the treatment of malignant melanoma.

J. Bitran, A. Masiel, P. Buttrick, 1981, Cancer treatment reports.

Cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphoma.

J. Ultmann, H. Golomb, J. Bitran, 1980, Annals of internal medicine.

Chronic lymphocytic leukemia: to transplant or not to transplant... that is the question?

C. Nabhan, J. Bitran, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic value of immunologic markers in adults with acute lymphoblastic leukemia.

J. Bitran, 1978, New England Journal of Medicine.

Gallium-67 scanning in the clinical evaluation of human immunodeficiency virus infection: indications and limitations.

J. Bitran, C. Bekerman, 1988, Seminars in nuclear medicine.

Clinicopathologic correlations demonstrating the failure of 67gallium scanning in determining response to radiotherapy.

L. Toledo-Pereyra, A. Churg, T. Demeester, 1978, Chest.

Oat cell carcinoma of the larynx. Response to combined modality therapy

L. Toledo-Pereyra, J. Bitran, G. Matz, 1978, Cancer.

Bone marrow, structure and function

J. Bitran, 1983 .

Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung.

M. Ratain, R. Larson, M. L. Le Beau, 1987, Blood.

Erlotinib has moderate single-agent activity in chemotherapy-naïve castration-resistant prostate cancer: final results of a phase II trial.

C. Nabhan, S. Newman, J. Bitran, 2009, Urology.

Medical Oncology Erlotinib Has Moderate Single-agent Activity in Chemotherapy-naïve Castration-resistant Prostate Cancer: Final Results of a Phase II Trial

C. Nabhan, S. Newman, J. Bitran, 2009 .

Role of sorafenib in overcoming resistance of chemotherapy-failure castration-resistant prostate cancer.

C. Nabhan, J. Bitran, T. Lestingi, 2014, Clinical genitourinary cancer.

Phase I study investigating the safety and feasibility of combining imatinib mesylate (Gleevec) with sorafenib in patients with refractory castration-resistant prostate cancer

M. Egorin, C. Nabhan, D. Villines, 2012, British Journal of Cancer.

Ascites as the major manifestation of systemic lupus erythematosus

D. McShane, J. Bitran, M. Ellman, 1976 .

The effects of inadvertent administration of antineoplastic agents prior to Ga-67 injection: concise communication.

J. Bitran, D. Pavel, U. Ryo, 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Carboplatin and vinblastine in advanced non-small-cell lung cancer: a phase II study

J. Herndon, M. Green, S. Graziano, 2004, Cancer Chemotherapy and Pharmacology.

Erlotinib in lung cancer.

C. Nabhan, J. Bitran, 2005, The New England journal of medicine.

Graft-versus-host disease and liver transplantation.

J. Bitran, A. DePaoli, 1992, Annals of internal medicine.

High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry.

D. Berry, J. Klein, H. Parnes, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic value of the estrogen receptor level in pathologic stage I and II adenocarcinoma of the breast

W. Recant, Richard W. Evans, J. Bitran, 1982, Journal of surgical oncology.

Dose intensification--a phase I study of ifosfamide with vinorelbine (Navelbine): rationale and study design in advanced non-small cell lung cancer.

E. Vokes, B. Samuels, H. Golomb, 1995, Seminars in Oncology.

Staging and therapy of orbital lymphomas

W. Recant, J. Bitran, U. Kalokhe, 1986, Cancer.

Malignancies of undetermined primary origin.

J. Ultmann, J. Bitran, 1992, Disease-a-month : DM.

Phase II trial of teniposide in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial.

G. Locker, J. Khandekar, J. Bitran, 1986, Cancer treatment reports.

Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study

P. Zinzani, N. Bartlett, J. Kuruvilla, 2022, Leukemia & lymphoma.

Central nervous system involvement in patients with histiocytic lymphoma, diffuse type [letter]

Jb Miller, J. Ultmann, H. Golomb, 1978 .

Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).

Alan M. Miller, J. Armitage, J. Vose, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Trial of vindesine, etoposide, and cisplatin in patients with previously treated, advanced-stage, non-small cell bronchogenic carcinoma.

K. Albain, S. Noble, T. Demeester, 1984, Cancer treatment reports.

Hematopoietic SCT for mantle cell lymphoma: is it the standard of care?

J. Mehta, C. Nabhan, J. Bitran, 2010, Bone Marrow Transplantation.

Treatment and Prognosis of Orbital Non‐Hodgkin's Lymphomas

R. Weichselbaum, L. Platanias, Srinivasan Vijayakumar, 1992, American journal of clinical oncology.

Funding for clinical (patient-oriented) oncology research: current status and recommendations for improvement. American Society of Clinical Oncology.

P. Scardino, B. Weber, K. Offit, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Arthritis Rounds: Ascites as the major manifestation of systemic lupus erythematosus.

D. McShane, J. Bitran, M. Ellman, 1976, Arthritis and rheumatism.

A Phase I Evaluation of Oral CI-1033 in Combination with Paclitaxel and Carboplatin as First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer

P. Ellis, J. Hamm, P. Lenehan, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Scintigraphic evaluation of sarcomata in children and adults by Ga67 citrate

M. Simon, H. Golomb, J. Bitran, 1978, Cancer.

Mantle Zone Lymphoma With Prostate Gland Enlargement: A Case Report

J. Bitran, Yanxia Li, Krishna Doshi, 2022, Cureus.

Non‐hodgkin's lymphoma, poorly differentiated lymphocytic and mixed cell types. Results of sequential staging procedures, response to therapy, and survival of 100 patients

J. Kinzie, J. Ultmann, H. Golomb, 1978, Cancer.

A Retrospective Study of Double‐hit Lymphomas in Elderly Patients (Aged > 70 Years): Overall Outcomes

J. Bitran, I. Almanaseer, Phillip D. Knouse, 2018, Clinical lymphoma, myeloma & leukemia.

A 10‐year experience with combined modality therapy for stage III small cell lung carcinoma

K. Albain, H. Golomb, J. Bitran, 1986, Cancer.

Tobacco control: reducing cancer incidence and saving lives. American Society of Clinical Oncology.

P. Scardino, B. Weber, K. Offit, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breast conserving surgery and definitive irradiation for early stage breast cancer.

D. Hallahan, D. Spelbring, R. Weichselbaum, 1989, International journal of radiation oncology, biology, physics.

Mitomycin-C/5-fluorouracil/leucovorin and hyperfractionated radiation therapy for rectal carcinoma: a phase II study with long-term follow-up.

L. Prasad, C. Nabhan, B. Samuels, 2007, Clinical colorectal cancer.

Combined modality therapy for stage IIIMO non‐small cell lung cancer. A five‐year experience

Thomas Demeester, H. Golomb, S. Newman, 1984, Cancer.

A phase II pilot trial investigating the efficacy and activity of single agent granulocyte macrophage colony-stimulating factor as maintenance approach in castration – resistant prostate cancer patients responding to chemotherapy

C. Nabhan, J. Bitran, T. Lestingi, 2011, Avicenna Journal of Medicine.

Phase IIIb randomized study of lenalidomide plus rituximab (R2) followed by maintenance in relapsed/refractory NHL: Analysis of patients with double-refractory or early relapsed follicular lymphoma (FL).

K. Kolibaba, K. Foon, A. Yacoub, 2017 .

The Abscopal Effect Exists in Non-small Cell Lung Cancer: A Case Report and Review of the Literature

J. Bitran, 2019, Cureus.

Mitoxantrone, vincristine, and 5-fluorouracil with leucovorin modulation as induction chemotherapy prior to high-dose intensification in metastatic breast cancer

R. Mick, J. Bitran, S. Myers, 1993, Breast Cancer Research and Treatment.

Phase II study of carboplatin in previously untreated patients with metastatic small cell lung carcinoma.

M. Deutsch, S. Purl, H. Golomb, 1987, Cancer treatment reports.

Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).

T. Demeester, H. Golomb, J. Bitran, 1978, JAMA.

Effect of sorafenib on chemotherapy resistance and refractoriness in castration-resistant prostate cancer (CRPC).

C. Nabhan, J. Bitran, T. Lestingi, 2016, Journal of Clinical Oncology.

A phase 1/2 study of ixazomib in place of bortezomib or carfilzomib in a subsequent line of therapy for patients with multiple myeloma refractory to their last bortezomib or carfilzomib combination regimen.

T. Spektor, J. Berenson, J. Hrom, 2022, Experimental hematology.

Replacement of ixazomib for relapsed/refractory multiple myeloma patients refractory to a bortezomib or carfilzomib-containing combination therapy.

R. Moss, T. Spektor, A. Cartmell, 2017 .

Patterns of gallium-67 scintigraphy in patients with acquired immunodeficiency syndrome and the AIDS related complex.

R. Weinstein, J. Bitran, U. Ryo, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

VP16-213 in combined modality treatment of small cell carcinoma of the lung.

T. Demeester, H. Golomb, S. Newman, 1982, European journal of cancer & clinical oncology.

Patterns of Care in Follicular Lymphoma (FL): Are Minorities Being Treated Differently? Report from the National LymphoCare Study (NLCS).

J. Hainsworth, C. Nabhan, Michael D. Taylor, 2007 .

Cost-effectiveness analysis: sleeping with an enemy or a friend?

J. Bitran, S. Gulati, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combined modality therapy for stage III(MO) non-oat cell bronchogenic carcinoma

L. Rubenstein, M. Griem, T. Demeester, 1978 .

Primary Central Nervous System Lymphoma With Systemic Recurrence

J. Bitran, Phillip D. Knouse, Sasirekha Pandravada, 2021, Cureus.

Pulmonary AL amyloidosis: A review and update on treatment options

J. Bitran, Nahren Asado, B. Shah, 2022, Annals of medicine and surgery.

B. Adley, J. Bitran, A. Chandran, 2020, Cureus.

Small-cell carcinoma of the lung: the prognostic significance of stage on survival.

M. Griem, T. Demeester, H. Golomb, 1979, European journal of cancer.

High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report.

R. Mick, T. Gilewski, J. Bitran, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose consolidation therapy with autologous stem cell rescue in stage IV breast cancer.

R. Mick, J. Bitran, S. Williams, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multimodality therapy of stage III adenocarcinoma of the breast

W. Recant, J. Bitran, H. Rochman, 1983, Journal of surgical oncology.

Gallium 67 scans in small cell carcinoma.

H. Golomb, J. Bitran, C. Bekerman, 1979, Journal of the American Medical Association (JAMA).

Histiocytic lymphoma: response to chemotherapy.

J. Ultmann, H. Golomb, J. Bitran, 1982, Annals of Internal Medicine.

Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancer.

S. Hanauer, B. Samuels, J. Bitran, 1996, Bone marrow transplantation.

Overcoming chemotherapy resistance in patients (pts) with chemotherapy-failure, castration-resistant prostate cancer (CRPC) with sorafenib.

C. Nabhan, J. Bitran, T. Lestingi, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survival of patients with lung cancer treated with vincristine and actinomycin D. An unsuccessful trial

J. Bitran, L. Cohen, R. Desser, 1976, Cancer.

Remission of metastatic adenocarcinoma of the colon.

J. Bitran, C. Shapiro, R. Shapiro, 1983, Journal of the American Medical Association (JAMA).

Adriamycin-radiotherapy interaction.

T. Demeester, H. Golomb, J. Bitran, 1977, Annals of internal medicine.

The Anatomy of Hope: How People Prevail in the Face of Illness

J. Bitran, 2004 .

Pleural Involvement in Stage IIIMO Non‐Small‐Cell Bronchogenic Carcinoma A Need to Differentiate Subtypes

A. Little, K. Albain, M. Griem, 1986, American journal of clinical oncology.